Rankings
▼
Calendar
DYN FY 2023 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DYN
Dyne Therapeutics, Inc.
$3B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$242M
Net Income
-$236M
EPS (Diluted)
$-3.95
Cash Flow
Operating Cash Flow
-$188M
Free Cash Flow
-$189M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$165M
Total Liabilities
$74M
Stockholders' Equity
$91M
Cash & Equivalents
$122M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$2M
$0
—
Operating Income
-$242M
-$171M
-41.6%
Net Income
-$236M
-$168M
-40.4%
← Q4 2022
All Quarters
Q1 2023 →